Skip to main content
Top
Published in: Journal of General Internal Medicine 9/2009

01-09-2009 | Original Article

Predictors of Outcome After Exacerbation of Chronic Obstructive Pulmonary Disease

Authors: Angeliki M. Tsimogianni, MD, MRCP, PhD, Spyros A. Papiris, MD, FCCP, Georgios T. Stathopoulos, MD, Effrosyni D. Manali, MD, Charis Roussos, MD, MSc, PhD, MRS, FRCP(©), Anastasia Kotanidou, MD, PhD

Published in: Journal of General Internal Medicine | Issue 9/2009

Login to get access

Abstract

BACKGROUND

The outcome after hospitalization for an exacerbation of chronic obstructive pulmonary disease (COPD) is unfavorable and uncertainty exists about factors predicting short and long-term prognosis.

OBJECTIVE

To identify clinical predictors of length of hospital stay (LOS) and three-year mortality after COPD exacerbations requiring hospitalization.

DESIGN

Retrospective analysis of prospectively collected data.

PARTICIPANTS AND METHODS

All consecutive patients hospitalized with COPD exacerbation were enrolled. Disease severity was estimated by FEV1, body mass index (BMI), Medical Research Council (MRC) chronic dyspnoea scale, previous hospitalizations, need for long-term oxygen treatment (LTOT), arterial oxygen and carbon dioxide partial pressures (PaO2 and PaCO2), pH and respiratory rate. Outcome was assessed by LOS and three-year mortality.

MAIN RESULTS

Out of 81 patients enrolled, three-year mortality data were available for 61. LOS was related to BMI, MRC scale and respiratory rate. Three-year mortality was related to FEV1, BMI, MRC scale, LTOT, and PaCO2. Multiple logistic regression analysis demonstrated that MRC scale was the only independent determinant of LOS, [p = 0.001, odds ratio (OR) 7.67 (95% CI 2.50–23.41)], whereas MRC scale and BMI predicted three-year mortality, [p = 0.001, OR 8.28 (95% CI 2.25–30.47) and p = 0.006, OR 6.91 (95% CI 1.74–27.48), respectively]. Cox regression analysis demonstrated identical results. Using receiver-operator-optimized thresholds for these variables (MRC > 2 and BMI < 25 kg/m2), we propose a prediction model that accurately determines three-year mortality risk.

CONCLUSIONS

In this study, MRC scale and BMI predicted outcome after COPD hospitalization. Pending further validation, this predictive model may contribute to identify patients with poor outcome even when spirometric data are unavailable.
Literature
1.
go back to reference Global strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Lung Disease (GOLD) report updated November 2008. Available at: http://www.goldcopd.com/. Accessed 11th June 2009. Global strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Lung Disease (GOLD) report updated November 2008. Available at: http://​www.​goldcopd.​com/​. Accessed 11th June 2009.
2.
go back to reference Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007;29:1224–38.PubMedCrossRef Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007;29:1224–38.PubMedCrossRef
3.
go back to reference Connors AFJ, Dawson NV, Thomas C, Harrell FE, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus W. Outcomes following acute exacerbation of severe chronic obstructive airways disease. Am J Respir Crit Care Med. 1996;154:959–67.PubMed Connors AFJ, Dawson NV, Thomas C, Harrell FE, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus W. Outcomes following acute exacerbation of severe chronic obstructive airways disease. Am J Respir Crit Care Med. 1996;154:959–67.PubMed
4.
go back to reference Groenewegen K, Schols A, Wouters E. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124:459–67.PubMedCrossRef Groenewegen K, Schols A, Wouters E. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124:459–67.PubMedCrossRef
5.
go back to reference Mushlin AI, Black ER, Connolly CA, Buonaccorso KM, Eberly SW. The necessary length of hospital stay for chronic pulmonary disease. JAMA. 1991;266(1):80–3.PubMedCrossRef Mushlin AI, Black ER, Connolly CA, Buonaccorso KM, Eberly SW. The necessary length of hospital stay for chronic pulmonary disease. JAMA. 1991;266(1):80–3.PubMedCrossRef
6.
go back to reference Villalta J, Sequeira E, Cereijo AC, Sisó A, de la Sierra A. Factors predicting a short length of stay for acute exacerbations of chronic obstructive pulmonary disease. Med Clin (Barc). 2005;124(17):648–50.CrossRef Villalta J, Sequeira E, Cereijo AC, Sisó A, de la Sierra A. Factors predicting a short length of stay for acute exacerbations of chronic obstructive pulmonary disease. Med Clin (Barc). 2005;124(17):648–50.CrossRef
7.
go back to reference Gunen H, Hacievliyagil SS, Kosar F, Mutlu LC, Gulbas G, Pehlivan E, Sahin I, Kizkin O. Factors affecting survival of hospitalised patients with COPD. Eur Respir J. 2005;26(2):234–41.PubMedCrossRef Gunen H, Hacievliyagil SS, Kosar F, Mutlu LC, Gulbas G, Pehlivan E, Sahin I, Kizkin O. Factors affecting survival of hospitalised patients with COPD. Eur Respir J. 2005;26(2):234–41.PubMedCrossRef
8.
go back to reference Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925–31.PubMedCrossRef Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925–31.PubMedCrossRef
9.
go back to reference Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing. 2005;34(5):491–6.PubMedCrossRef Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing. 2005;34(5):491–6.PubMedCrossRef
10.
go back to reference Menzies R, Gibbons W, Goldberg P. Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure. Chest. 1995;398–405. Menzies R, Gibbons W, Goldberg P. Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure. Chest. 1995;398–405.
11.
go back to reference Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J. 2003;21(Suppl 41):46s–53s.CrossRef Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J. 2003;21(Suppl 41):46s–53s.CrossRef
12.
go back to reference Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5- year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434–40.PubMedCrossRef Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5- year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434–40.PubMedCrossRef
13.
go back to reference Calverley P, Anderson J, Celli B, Ferguson GT, Jenkins Ch, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–89.PubMedCrossRef Calverley P, Anderson J, Celli B, Ferguson GT, Jenkins Ch, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–89.PubMedCrossRef
14.
go back to reference Tsimogianni AM, Papiris SA, Kanavaki S, Stathopoulos GT, Sotiropoulou C, Manali ED, Michalopoulou P, Roussos C, Kotanidou A. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease. Respirology, in press Tsimogianni AM, Papiris SA, Kanavaki S, Stathopoulos GT, Sotiropoulou C, Manali ED, Michalopoulou P, Roussos C, Kotanidou A. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease. Respirology, in press
15.
go back to reference American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med. 1995;152:1107–36. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med. 1995;152:1107–36.
16.
go back to reference Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21:347–60.PubMedCrossRef Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21:347–60.PubMedCrossRef
17.
go back to reference Celli B, Cote C, Mario J, Casanova C, Montes de Oca M, Mendez RA, Plata VP, Cabral HJ. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2004;350:1005–12.PubMedCrossRef Celli B, Cote C, Mario J, Casanova C, Montes de Oca M, Mendez RA, Plata VP, Cabral HJ. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2004;350:1005–12.PubMedCrossRef
18.
go back to reference Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–6.PubMed Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–6.PubMed
19.
go back to reference Kim S, Clark S, Camargo CA Jr. Mortality after an emergency department visit for exacerbation of chronic obstructive pulmonary disease. COPD. 2006;3(2):75–81.PubMedCrossRef Kim S, Clark S, Camargo CA Jr. Mortality after an emergency department visit for exacerbation of chronic obstructive pulmonary disease. COPD. 2006;3(2):75–81.PubMedCrossRef
20.
go back to reference Budweiser S, Jörres RA, Riedl T, Heinemann F, Hitzl AP, Windisch W, Pfeifer M. Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest. 2007;131(6):1650–8.PubMedCrossRef Budweiser S, Jörres RA, Riedl T, Heinemann F, Hitzl AP, Windisch W, Pfeifer M. Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest. 2007;131(6):1650–8.PubMedCrossRef
21.
go back to reference Ai-Ping C, Lee KH, Lim TK. In-hospital mortality and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD. A retrospective study. Chest. 2005;128:518–24.PubMedCrossRef Ai-Ping C, Lee KH, Lim TK. In-hospital mortality and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD. A retrospective study. Chest. 2005;128:518–24.PubMedCrossRef
22.
go back to reference Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF. Airway inflammation and etiology of acute exacerbation of chronic bronchitits. Chest. 2000;118(6):1557–65.PubMedCrossRef Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF. Airway inflammation and etiology of acute exacerbation of chronic bronchitits. Chest. 2000;118(6):1557–65.PubMedCrossRef
23.
go back to reference Van der Valk P, Monninkhof E, Van der Palen J, Zielhuis G, van Herwaarden C, Hendrix R. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease. Clin Infect Dis. 2004;39(7):980–6.PubMedCrossRef Van der Valk P, Monninkhof E, Van der Palen J, Zielhuis G, van Herwaarden C, Hendrix R. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease. Clin Infect Dis. 2004;39(7):980–6.PubMedCrossRef
24.
go back to reference Panagiotakos DB, Pitsavos C, Chrysohoou C, Risvas G, Kontogianni MD, Zampelas A, Stefanadis C. Epidemiology of overweight and obesity in Greek adult population: the ATTICA Study. Obes Res. 2004;12(12):1914–20.PubMedCrossRef Panagiotakos DB, Pitsavos C, Chrysohoou C, Risvas G, Kontogianni MD, Zampelas A, Stefanadis C. Epidemiology of overweight and obesity in Greek adult population: the ATTICA Study. Obes Res. 2004;12(12):1914–20.PubMedCrossRef
25.
go back to reference Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest. 1999;116:1632–7.PubMedCrossRef Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest. 1999;116:1632–7.PubMedCrossRef
26.
go back to reference Donaldson GC, Seemungal TAR, Blowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–52.PubMedCrossRef Donaldson GC, Seemungal TAR, Blowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–52.PubMedCrossRef
27.
go back to reference Almagro P, Calbo E, Ochoea de Echaguen A, Barreiro B, Quintana S, Heredia JL, Garau J. Mortality after hospitalisation for COPD. Chest. 2002;121:1441–8.PubMedCrossRef Almagro P, Calbo E, Ochoea de Echaguen A, Barreiro B, Quintana S, Heredia JL, Garau J. Mortality after hospitalisation for COPD. Chest. 2002;121:1441–8.PubMedCrossRef
28.
go back to reference Garcia-Aymeric J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors for readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58:100–5.CrossRef Garcia-Aymeric J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Risk factors for readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58:100–5.CrossRef
29.
go back to reference Pitta F, Troosters Th, Probst V, Spruit MA, Decramer M, Gosselink R. Physical activity and Hospitalization for Exacerbation of COPD. Chest. 2006;129:536–44.PubMedCrossRef Pitta F, Troosters Th, Probst V, Spruit MA, Decramer M, Gosselink R. Physical activity and Hospitalization for Exacerbation of COPD. Chest. 2006;129:536–44.PubMedCrossRef
30.
go back to reference Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28:1245–57.PubMedCrossRef Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28:1245–57.PubMedCrossRef
Metadata
Title
Predictors of Outcome After Exacerbation of Chronic Obstructive Pulmonary Disease
Authors
Angeliki M. Tsimogianni, MD, MRCP, PhD
Spyros A. Papiris, MD, FCCP
Georgios T. Stathopoulos, MD
Effrosyni D. Manali, MD
Charis Roussos, MD, MSc, PhD, MRS, FRCP(©)
Anastasia Kotanidou, MD, PhD
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 9/2009
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-1061-2

Other articles of this Issue 9/2009

Journal of General Internal Medicine 9/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.